Post on 15-Aug-2020
Running head: PHARMACOLOGY FOR NURSING CARE 1
Pharmacology for Nursing Care
Student’s Name:
Institutional Affiliation:
PHARMACOLOGY FOR NURSING CARE 2
Pharmacology for Nursing Care
Health regulatory agencies are of great significance since they help protect as well as
regulate public health at every level. The agencies ensure that safe and quality care is provided
by promoting safety, providing the necessary information about industry changes, monitoring
practitioners and facilities as well as foreseeing legal compliance and quality services. Health
care standards and regulations are important to enhance compliance and also the provision of
safe healthcare to every individual who assesses the system. In the U.S, regulations are normally
developed and implemented at all levels of government and also by private organizations. This
paper discusses the agonies that regulate prescribing by APRNs in Louisiana. It further
differentiates the regulations in Texas and Louisiana.
The agency that Regulate Advanced Practice Registered Nurse Prescribing in Louisiana
Independent prescribing refers to the ability of advanced practice registered nurses to prescribe
without limitation. In Louisiana, prescribing by the APRN is regulated by the Louisiana State
Board of Nursing. The goal of this agency is to safeguard the health and life of the citizens of
Louisiana. It ensures that a person who takes up the roles of advanced practice registered nurses
and registered nurses are competent. The goals of the agency include promoting regulatory
effectiveness, enhancing image and visibility of the Board, assuring efficient and timely
responses to nursing issues that affect the safety of patients, and identifying as well as regulating
evolving roles of the registered nurse and advanced practice registered nurse as a professional
while protecting the public. The agency requires a nurse to complete all the forms and
applications that are necessary correctly, accurately, and carefully. The agency requires an
APRN to apply for reinstatement of Prescriptive Authority if she/he had been awarded by LSBN
with PA privileges before but has not practiced within the last 12 months or more.
PHARMACOLOGY FOR NURSING CARE 3
Educational Requirements for Prescribing as an APRN in Louisiana
In this state, the credentials for prescriptive authority that are issues are calendar year,
and nurses are required to renew the licenses and credentials before their date of expiration.
Subsequent renewals are usually biennials. Every year APRNs are usually expected to undertake
six contact hours of continuing education in pharmacotherapeutics in their role and population to
maintain the prescriptive authority credential after issuance. If selected randomly during the
yearly audit procedure, the APRNS are expected to provide evidence of the CEs to LSBN. The
CE certificate of completion or documentation should indicate clearly the topics of
pharmacology that the APRN has completed. Another requirement is for one to have practiced in
the current clinical practice for at least 500 hours as an APRN within the last two years. Annual
continuing education for pharmacology is required to be at the advanced practice level and
related to the APRN’S licensed advanced role and population specialty/focus (Phillips, 2016).
Difference between the Regulations in Louisiana and Texas
In the state of Texas, there are limitations in relation to prescriptive authority for
Advanced Practice Registered Nurses. A physician must delegate prescriptive Authority through
a written document prescribed by law to an APRN or physician assistant through a prescriptive
authority agreement. For an APRN to qualify to be a party to a prescriptive authority agreement
the APRNs must have been issued by the BON with a prescriptive authorization number that is
valid, an explanation on the nature of the practice, setting or location, the categories and types of
drugs that APRN can prescribe and not prescribe, and a prescriptive authority quality assurance
and improvement plan. In addition to that, an APRN is required by the prescriptive authority to
have a DEA registration for controlled substances and registration with the TX Department of
Public Safety. On the other hand, in the state of Louisiana, the APRN, before engaging in
PHARMACOLOGY FOR NURSING CARE 4
practices that involve writing orders or prescriptions, the nurses are expected to obtain a letter of
approval from the Louisiana State Board of Nursing that shows approval for Prescriptive
Authority privileges in conjunction with the licensed physicians (Paulozzi, Strickler, Kreiner, &
Koris, 2015). The collaborating physician is expected to engage in clinical practice within the
state of Louisiana in the same, or a practice that is comparable in specialty, the scope of expertise
to that of the APRN. Nurse practitioners have the authority to prescribe medications, which
includes controlled substances as long as it is outlined in the collaborative practice agreement
parameters. In Louisiana, the APRNs are prohibited from writing prescriptions for controlled
substances for their family members or themselves. They are also prohibited from distributing or
prescribing controlled substances in regard to the treatment of intractable or chronic pain
(Gadbois, Miller, Tyler, D., & Intrator, 2015).
Actions Required to Prescribe in Louisiana
The state of Louisiana has a prescription monitoring program that was put in place to
give guidelines for effective and safe prescription (Brandeis University & United States of
America., 2018). This program comes in handy to eliminate issues like drug abuse, medical
errors, and, most importantly, to fight the opioid epidemic. All prescribers are required to register
PHARMACOLOGY FOR NURSING CARE 5
in this program. Through the program, they can receive regular training and education, which
would enable them to prescribe effectively. The Louisiana Board of pharmacy also has in place
regulations and procedures that healthcare providers should put in place when doing
prescriptions. The first and most important action is the verification of the patient requiring
medication. This includes doing a background medical check-up to ascertain that they genuinely
need the drug for health purposes. During the prescribing process, there is important information
that needs to be recorded, which include the prescriber’s information, prescription information,
patient information, drug information, and dispenser information.
During the Opioid crisis, a large number of teenagers would use older friends or family
members to get these drugs for them. Patient verification prevents issues of impersonation by
people just to get drugs and abuse them or sell them to addicted teens. It also eliminates cases
where patients with Opioid addiction get more opioid prescriptions. When a patient’s history
shows a past addiction, prescribing personnel can find alternative ways of medication. The
patient is also required to be medically examined to prove their compatibility with the medicine.
This prevents issues like reactions. The healthcare provider is also expected to educate the
patient on the risks and side effects of the medication. They also need to highlight issues of
PHARMACOLOGY FOR NURSING CARE 6
medicine counter-reaction with other substances they could be taking, such as alcohol. In cases
where the patient requiring a prescription is a minor, parental consent should be sought. This
eliminates cases where children abuse drugs behind their parents back. Such instances can
expose healthcare facilities to legal suits.
Controlled Substance Regulation
Controlled dangerous substances (CDS) in Louisiana include drugs such as cocaine,
heroin, marijuana, and also the compounds used to manufacture them. In this state, the controlled
dangerous substances are usually classified into five groups. These groups are usually known as
schedules. Schedule I is made up of the most dangerous drugs which have a high likelihood of
abuse and addiction, whereas they don’t have any medical significance. On the other hand,
schedule II, III, IV, and V drugs are less dangerous, have lower possibilities of abuse, and have
some identified medical value. The different schedules also attract different penalties for the
illegal possession of the CDS. Schedule I substances have different penalties depending on the
specific CDS involved, and the fine ranges between $5000 up to $600,000 and imprisonment of
up to 30 years. The penalty for schedule II substances also depends on the specific CDS
involved, and the fine ranges from $5000 to $600,000 and imprisonment of five or up to 30
PHARMACOLOGY FOR NURSING CARE 7
years. Schedule III substances attract a fine of up to $5000 and up to five years in prison.
Penalties for schedule IV substances attract a maximum fine of $5000 and up to 10 years in
prison. Schedule V substances usually attract a fine of up to $5000 and a maximum of 5 years in
prison. The manufacturers or distributors, if found guilty for unlawful of the CDS, also face hefty
fines and even prison time for the individuals involved.
A DEA number refers to a number that is assigned to enable a health provider to
prescribe medications legally, including controlled substances. In Louisiana, APRNs who would
like to prescribe controlled substances the requested DEA schedules need to be identified by the
CPA and Attestation of Collaborative practice. To obtain DEA regulations, I am expected to
provide a detailed description of the practice site of a family nurse practitioner, describe how the
patients I administer care to will benefit, identify the schedules of controlled substances I
anticipate to administer. In addition to that, to obtain the regulations as a family nurse
practitioner am also expected to explain the various conditions that will require the prescription
of controlled substances.
PHARMACOLOGY FOR NURSING CARE 8
References
Brandeis University, & United States of America. (2018). Prescription Drug Monitoring
Program: Louisiana State Profile.
Gadbois, E. A., Miller, E. A., Tyler, D., & Intrator, O. (2015). Trends in state regulation of nurse
practitioners and physician assistants, 2001 to 2010. Medical Care Research and
Review, 72(2), 200-219.
Paulozzi, L. J., Strickler, G. K., Kreiner, P. W., & Koris, C. M. (2015). Controlled substance
prescribing patterns—prescription behavior surveillance system, eight states,
2013. Morbidity and Mortality Weekly Report: Surveillance Summaries, 64(9), 1-14.
Phillips, S. J. (2016). 28th annual APRN legislative update: advancements continue for APRN
practice. The Nurse Practitioner, 41(1), 21-48.